THROMBOLEX Announces Interim RAPID-PE Results Showing Favorable Safety and Reproducible Multicenter Results in Acute Pulmonary Embolism
Mechanically channeled thrombolysis procedure disrupts and dissolves thrombus in a single on-the-table session
Independent industry coverage
FDA • MedTech • Biotechnology • Healthcare Business
Medical Device News and MedTech Industry News
Stay informed with the latest medical device news and developments shaping the global MedTech industry. Medical Device News Magazine delivers coverage of innovative medical technologies, FDA approvals and clearances, clinical trials, product launches, and emerging technologies transforming patient care.
Explore news and insights from medical device manufacturers, healthcare technology companies, researchers, and industry leaders. From advances in medical imaging and artificial intelligence to regulatory developments, funding, and acquisitions, our coverage helps healthcare professionals, industry executives, and investors stay informed about the evolving medical device landscape.
Mechanically channeled thrombolysis procedure disrupts and dissolves thrombus in a single on-the-table session
FDA clearance and CE Mark for latest Affera™ Prism-2 Mapping Software expand cardiac mapping capabilities. CE Mark for PulseSelect ProxBox™ Adapter with Proximity Indicator software adds real-time tissue proximity feedback
colimiR-3D, a novel microRNA-based blood test, is designed to enable earlier intervention and personalized management of adolescent idiopathic scoliosis based on progression risk

Fewer people on intake, faster turnaround, and no lost cases: Relu’s new automation captures and centralises every scan and Rx from every source within a minute of arrival
Ensuring that patients worldwide have access to innovative treatments is a significant challenge, mainly due to differences in healthcare systems, availability of medicines, treatment costs and cancer diagnostics
Very soft, 100% TPU combines 65A performance with chemical resistance, thin-wall processability, and manufacturing versatility
Collaboration expands access to Lunit’s AI-powered pathology platform by combining it with Discovery Life Sciences’ global biospecimen and specialty laboratory capabilities, enabling standardized tissue insights for biomarker research and drug development
A redesigned patient experience drives engagement from prevention through survivorship, while chart-aware risk intelligence surfaces guideline-based recommendations in EHR workflows

A companion app can make a device easier to use, generate valuable real-world data, and strengthen a product’s position with clinicians and payers

A Knoxville nurse on nausea, water, protein, and the symptoms that mean you should call before your next dose.

Any connected device can be exploited. Recognizing that truth, we must try to ensure that when a vulnerability inevitably emerges, there’s a plan, and everyone involved knows what to do next

The future of robotic surgery won’t be defined solely by how advanced the robot becomes. It will also be defined by how well the technologies around it help clinicians deliver safer, more consistent and more patient-centered care
The investment is expected to bring together Zylox-Tonbridge’s peripheral vascular and neurovascular businesses with LifeTech’s aortic and structural heart businesses, creating a comprehensive portfolio across four key therapeutic areas
Company’s first-of-a-kind intelligent imaging system aims to expand patient access, streamline
high-quality cardiac care, and establish the foundation for future robotic interventions
Proceeds will fuel BRIJ Medical’s continued commercial expansion of BRIJ-SEAL™ and the upcoming launch of BRIJ-Ag™, building on strong investor confidence and growing market momentum
The company that invented VR visual testing, now trusted in 2,500+ clinics for more than 6 million eye exams, will add immersive, interactive IOL simulation—bringing testing, diagnostics and simulation onto one platform
ublished study reports PulseAI model delivers up to 10x performance improvement when used with leading wearables
BOLT-DVT, a recent prospective, multicenter Investigational Device Exemption (IDE) trial, demonstrated first-line use of computer assisted vacuum thrombectomy (CAVT) for DVT is safe and effective
Temporary knee spacer delivers antibiotics directly to an infected joint while providing load-bearing structural support during treatment
For the first time, U.S. CardioMEMS patients will be able to view pulmonary artery pressure (PAP) readings and receive personalized medication updates through the CardioGuide HF App. Rising PAP can signal worsening heart failure weeks before patients experience symptoms.
New capabilities help patients take a more active role in their care and stay connected to their care teams between doctor visits
Channel Medsystems, Inc., a privately held medical technology company dedicated to raising the standard of care for women with heavy menstrual bleeding and dysmenorrhea, announced
Presentations will address 24-month treatment outcomes, systemic antibiotic exposure, and new treatment strategies for recalcitrant periprosthetic joint infection
The 6-month target lesion primary patency (TLPP)1 and access circuit primary patency (ACPP)2 for patients in the arteriovenous fistula (AVF) cohort were 92.7% and 76.7%, respectively. The real-world patency results observed in the WRAP Global Registry are higher than the patency results from the WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal trial, validating the already favorable performance of the device
Nearly nine out of 10 patients experienced a clinical benefit at six months

Beske joins Getinge from Philips where she most recently served as Senior Vice President, Business Unit Leader for Image Guided Therapy Devices

Ryan brings more than 25 years of strategic, operational and capital allocation expertise to support the company’s next phase of growth
Sayer has played a pivotal role in advancing innovations that have transformed how people monitor and manage disease and has a strategic and operations record delivering significant growth
The Nomination Committee has been appointed in accordance with the principles adopted by the Annual General Meeting and consists of representatives of the three largest shareholders by voting rights as of September 30, 2026, as well as the Chair of the Board (convener)

Dave brings more than 30 years of experience in precision motion, automation and advanced technology markets.